Novel lethal mouse mutants produced in balancer chromosome screens

Gene Expression Patterns

Volumn 6, Issue 6, 2006, Pages 653-665

  Hentges, Kathryn E ^a   Nakamura, Hisashi ^a   Furuta, Yasuhide ^b   Yu, Yuejin ^c   Thompson, Debrah M ^d   O'Brien, William ^a   Bradley, Allan ^d   Justice, Monica J ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^c ROSWELL PARK CANCER INSTITUTE   (United States)

^d WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

Author keywords

Balancer chromosome; Cardiovascular development; Embryonic development; Gastrulation defect; Lethal mutation; Mutagenesis screen; Peri natal lethal; Post natal lethal

Indexed keywords

BRCA1 PROTEIN; PROTEIN P53; UNCLASSIFIED DRUG; WNT PROTEIN; WNT3 PROTEIN;

ALLELE; ANGIOGENESIS; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BREAST CANCER; CARCINOGENESIS; CHROMOSOME 11; CHROMOSOME 4; CHROMOSOME ANALYSIS; CONTROLLED STUDY; DEVELOPMENTAL STAGE; EMBRYO DEATH; FEMALE; GASTRULATION; GENE IDENTIFICATION; GENE MAPPING; GENE MUTATION; GENE TARGETING; GENETIC COMPLEMENTATION; GESTATION PERIOD; HEART DEVELOPMENT; MALE; MOUSE; MOUSE MUTANT; MUTAGENESIS; NEURAL TUBE; NIDATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; PLACENTA DEVELOPMENT; PRIORITY JOURNAL; TIME;

ANIMALS; ANIMALS, NEWBORN; CHROMOSOME DELETION; EMBRYO; EMBRYONIC DEVELOPMENT; GENES, BRCA1; GENES, LETHAL; GENETIC COMPLEMENTATION TEST; GESTATIONAL AGE; HOMOZYGOTE; MICE; MICE, MUTANT STRAINS; MUTAGENICITY TESTS; MUTATION;

ANIMALIA;

EID: 33646788051     PISSN: 1567133X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.modgep.2005.11.015     Document Type: Article

References (58)

1. Barbacci E., Reber M., Ott M.O., Breillat C., Huetz F., and Cereghini S. Variant hepatocyte nuclear factor 1 is required for visceral endoderm specification. Development 126 (1999) 4795-4805
2. Beigneux A.P., Kosinski C., Gavino B., Horton J.D., Skarnes W.C., and Young S.G. ATP-citrate lysase deficiency in the mouse. J. Biol. Chem. 279 (2004) 9557-9564
3. Bierkamp C., McLaughlin K.J., Schwarz H., Huber O., and Kemler R. Embryonic heart and skin defects in mice lacking plakoglobin. Dev. Biol. 180 (1996) 780-785
4. Cahana A., Jin X.L., Reiner O., Wynshaw-Boris A., and O'Neill C. A study of the nature of embryonic lethality in Lis1-/- mice. Mol. Reprod. Dev. 66 (2003) 134-142
5. Carter M.G., Johns M.A., Zeng X., Zhou L., Zink M.C., Mankowski J.L., Donovan D.M., and Baylin S.B. Mice deficient in the candidate tumor suppressor gene Hic1 exhibit developmental defects of structures affected in the Miller-Dieker syndrome. Hum. Mol. Genet. 9 (2000) 413-419
6. Chan E.Y., Nasir J., Gutekunst C.A., Coleman S., Maclean A., Maas A., Metzler M., Gertsenstein M., Ross C.A., Nagy A., and Hayden M.R. Targeted disruption of Huntington-Associated protein-1 (Hap1) results in post-natal death due to depressed feeding behavior. Hum. Mol. Genet. 11 (2002) 945-959
7. Chen C.M., and Behringer R.R. Ovca1 regulates cell proliferation, embryonic development, and tumorigenesis. Genes Dev. 18 (2004) 320-332
8. Coffinier C., Thepot D., Babinet C., Yaniv M., and Barra J. Essential role for the homeoprotein vHNF1/HNF1beta in visceral endoderm differentiation. Development 126 (1999) 4785-4794
9. Davis A.P., and Justice M.J. An Oak Ridge legacy: the specific locus test and its role in mouse mutagenesis. Genetics 148 (1998) 7-12
10. Gangloff Y.-G., Mueller M., Dann S.G., Svoboda P., Sticker M., Spetz J.-F., Um S.-H., Brown E.J., Cereghini S., Thomas G., and Kozma S.C. Disruption of the mouse mTOR gene leads to early postimplantation lethality and prohibits embryonic stem cell development. Mol. Cell. Biol. 24 (2004) 9508-9516
11. Gowen L.C., Johnson B.L., Latour A.M., Sulik K.K., and Koller B.H. Brca1 deficiency results in early embryonic lethality characterized by neuroepithelial abnormalities. Nat. Genet. 12 (1996) 191-194
12. Hagge-Greenberg A., Snow P., and O'Brien T.P. Establishing an ENU mutagenesis screen for the piebald region of mouse Chromosome 14. Mamm. Genome 12 (2001) 938-941
13. Hakem R., de la Pompa J.L., Sirard C., Mo R., Woo M., Hakem A., Wakeham A., Potter J., Reitmair A., Billia F., Firpo E., Hui C.C., Roberts J., Rossant J., and Mak T.W. The tumor suppressor gene Brca1 is required for embryonic cellular proliferation in the mouse. Cell 85 (1996) 1009-1023
14. Hakem R., Hakem A., Duncan G.S., Henderson J.T., Woo M., Soengas M.S., Elia A., de la Pompa J.L., Kagi D., Khoo W., Potter J., Yoshihida R., Kaufman S.A., Lowe S.W., Penninger J.M., and Mak T.W. Differential requirement for caspase 9 in apoptotic pathways in vivo. Cell 94 (1998) 339-352
15. Hall J.M., Lee M.K., Newman B., Morrow J.E., Anderson L.A., Huey B., and King M.C. Linkage of early-onset familial breast cancer to chromosome 17q21. Science 250 (1990) 1684-1689
16. Hamblet N.S., Lijam N., Ruiz-Lozano P., Wang J., Yang Y., Luo Z., Mei L., Chien K.R., Sussman D.J., and Wynshaw-Boris A. Dishevelled 2 is essential for cardiac outflow tract development, somite segmentation, and neural tube closure. Development 129 (2002) 5827-5838
17. Harrelson Z., Kelly R.G., Goldin S.N., Gibson-Brown J.J., Boilag R.J., Silver L.M., and Papaioannou V.G. Tbx2 is essential for patterning the atrioventricular canal and for morphogenesis of the outflow tract during heart development. Development 131 (2004) 5041-5052
18. Hentges K., Thompson K., and Peterson A. The flat-top gene is required for the expansion and regionalization of the telencephalic primordium. Development 126 (1999) 1601-1609
19. Hentges K.E., Sirry B., Gingeras A.C., Sarbassov D., Sonenberg N., Sabatini D., and Peterson A.S. FRAP/mTOR is required for proliferation and patterning during embryonic development in the mouse. Proc. Natl. Acad. Sci. USA 98 (2001) 13796-13801
20. Hentges K.E., and Justice M.J. Checks and balancers: balancer chromosomes to facilitate genome annotation. Trends Genet. 20 (2004) 252-259
21. Hentges K.E., Kyttala M., Justice M.J., and Peltonen L. Comparative physical maps of the human and mouse Meckel syndrome critical regions. Mamm. Genome 15 (2004) 252-264
22. Herron B.J., Lu W., Rao C., Liu S., Peters H., Bronson R.T., Justice M.J., McDonald J.D., and Beier D.R. Efficient generation and mapping of recessive developmental mutations using ENU mutagenesis. Nat. Genet. 30 (2002) 185-189
23. Hitotsumachi S., Carpenter D.A., and Russell W.L. Dose-repetition increases the mutagenic effectiveness of N-ethyl-N-nitrosourea in mouse spermatogonia. Proc. Natl. Acad. Sci. USA 82 (1985) 6619-6621
24. Huang F., Wagner M., and Siddiqui M.A. Ablation of the CLP-1 gene leads to down-regulation of the HAND1 gene and abnormality of the left ventricle of the heart and fetal death. Mech. Dev. 121 (2004) 559-572
25. Ito M., Okano H.J., Darnell R.B., and Roeder R.G. The TRAP100 component of the TRAP/Mediator complex is essential in broad transcriptional events and development. EMBO J. 21 (2002) 3464-3475
26. Jin O., Harpal K., Ang S.-L., and Rossant J. Otx2 and HNF3β genetically interact in anterior patterning. Int. J. Dev. Biol. 45 (2001) 357-365
27. Jun J.E., Wilson L.E., Vinuesa C.G., Lesage S., Blery M., Miosge L.A., Cook M.C., Kucharska E.M., Hara H., Penninger J.M., Domashenz H., Hong N.A., Glynne R.J., Nelms K.A., and Goodnow C.C. Identifying the MAGUK protein Carma-1 as a central regulator of humoral immune responses and atopy by genome-wide mouse mutagenesis. Immunity 18 (2003) 751-762
28. Kasarskis A., Manova K., and Anderson K.V. A phenotype-based screen for embryonic lethal mutations in the mouse. Proc. Natl. Acad. Sci. USA 95 (1998) 7485-7490
29. Kile B.T., Hentges K.E., Clark A.T., Nakamura H., Salinger A.P., Liu B., Box N., Stockton D.W., Johnson R.L., Behringer R.R., Bradley A., and Justice M.J. Functional genetic analysis of mouse chromosome 11. Nature 425 (2003) 81-86
30. Kinder S.J., Tsang T.A., Ang S.-L., Behringer R.R., and Tam P.T. Defects of the body plan of mutant embryos lacking Lim1, Otx2, or Hnf3β activity. Int. J. Dev. Biol. 45 (2001) 347-355
31. Kuhnert F., Campagnolo L., Xiong J.W., Lemons D., Fitch M.J., Zou Z., Kiosses W.B., Gardner H., and Stuhlmann H. Dosage-dependent requirement for mouse Vezf1 in vascular system development. Dev. Biol. (2005)
32. Kuida K., Haydar T.F., Kuan C.-Y., Gu Y., Taya C., Karasuyama H., Su M.-S., Rakic P., and Flavell R. Reduced apoptosis and cytochrome c-mediated caspase activation in mice lacking caspase 9. Cell 94 (1998) 325-337
33. Lambrechts D., and Carmeliet P. Genetics in zebrafish, mice, and humans to dissect congenital heart disease: insights in the role of VEGF. Curr. Top. Dev. Biol. 62 (2004) 189-224
34. Lane D.M., Boatman K.K., and McConathy W.J. Serum lipids and apolipoproteins in women with breast masses. Breast Cancer Res. Treat. 34 (1995) 161-169
35. Liu C.Y., Flesken-Nikitin A., Li S., Zeng Y., and Lee W.H. Inactivation of the mouse Brca1 gene leads to failure in the morphogenesis of the egg cylinder in early postimplantation development. Genes Dev. 10 (1996) 1835-1843
36. Morasso M.I., Grinberg A., Robinson G., Sargent T.D., and Mahon K.A. Placental failure in mice lacking the homeobox gene Dlx3. Proc. Natl. Acad. Sci. USA 96 (1999) 162-167
37. Murakami M., Ichisaka T., Maeda M., Oshiro N., Hara K., Edenhofer F., Kiyama H., Yonezawa K., and Yamanaka S. mTOR is essential for growth and proliferation in early mouse embryos and embryonic stem cells. Mol. Cell. Biol. 24 (2004) 6710-6718
38. Naiche L.A., and Papaioannou V.E. Loss of Tbx4 blocks hindlimb development and affects vascularization and fusion of the allantois. Development 130 (2003) 2681-2693
39. Nishijima I., Mills A., Qi Y., Mills M., and Bradley A. Two new balancer chromosomes on mouse chromosome 4 to facilitate functional annotation of human chromosome 1p. Genesis 36 (2003) 142-148
40. Noveroske J.K., Lai L., Gaussin V., Northrop J.L., Nakamura H., Hirschi K.K., and Justice M.J. Quaking is essential for blood vessel development. Genesis 32 (2002) 218-230
41. Pittman D.L., and Schimenti J.C. Midgestation lethality in mice deficient for the RecA-related gene, Rad51d/Rad51l3. Genesis 26 (2000) 167-173
42. Rinchik E.M., and Carpenter D.A. N-ethyl-N-nitrosourea mutagenesis of a 6- to 11-cM subregion of the Fah-Hbb interval of mouse chromosome 7: completed testing of 4557 gametes and deletion mapping and complementation analysis of 31 mutations. Genetics 152 (1999) 373-383
43. Rinchik E.M., Carpenter D.A., and Johnson D.K. Functional annotation of mammalian genomic DNA sequence by chemical mutagenesis: a fine-structure genetic mutation map of a 1- to 2-cM segment of mouse chromosome 7 corresponding to human chromosome 11p14-p15. Proc. Natl. Acad. Sci. USA 99 (2002) 844-849
44. Ruiz P., Brinkmann V., Ledermann B., Behrend M., Grund C., Thalhammer C., Vogel F., Birchmeier C., Gunthert U., Franke W.W., and Birchmeier W. Targeted mutation of plakoglobin in mice reveals essential functions of desmosomes in the embryonic heart. J. Cell Biol. 135 (1996) 215-225
45. Salonen R., and Paavola P. Meckel syndrome. J. Med. Genet. 35 (1998) 497-501
46. Shawlot W., Wakamiya M., Kwan K.M., Kania A., Jessel T.M., and Behringer R.R. Lim1 is required for both primative streak-derived tissues and visceral endoderm for head formation in the mouse. Development 126 (1999) 4925-4932
47. Srivastava A.K., Mohan S., Wergedal J.E., and Baylink D.J. A genomewide screening of N-ethyl-N-nitrosourea-mutagenized mice for musculoskeletal phenotypes. Bone 33 (2003) 179-191
48. Stark K., Vainio S., Vassileva G., and McMahon A.P. Epithelial transformation of metanephric mesenchyme in the developing kidney regulated by Wnt-4. Nature 372 (1994) 679-683
49. Thomas T., Voss A.K., Petron P., and Gruss P. The murine gene, Traube, is essential for the growth of preimplantation embryos. Dev. Biol. 227 (2000) 324-342
50. Toyo-oka K., Shionoya A., Gambello M.J., Cardoso C., Leventer R., Ward H.L., Ayala R., Tsai L.H., Dobyns W., Ledbetter D., Hirotsune S., and Wynshaw-Boris A. 14-3-3epsilon is important for neuronal migration by binding to NUDEL: a molecular explanation for Miller-Dieker Syndrome. Nat. Genet. 34 (2003) 274-285
51. Truett G.E., Heeger P., Mynatt R.L., Truett A.A., Walker J.A., and Warman M.L. Preparation of PCR-quality mouse genomic DNA with hot sodium hydroxide and tris (HotSHOT). Biotechniques 29 (2000) 52 54
52. Wang Y., Putman C.D., Kane M.F., Zhang W., Edelmann L., Russell R., Carrion D.V., Chin L., Kucherlapati R., Kolodner R.D., and Edelmann W. Mutation in Rpa1 results in defective DNA double-strand break repair, chromosomal instability, and cancer in mice. Nat. Genet. 37 (2005) 750-755
53. Witke W., Sutherland J.D., Sharpe A., Arai M., and Kwiatkowski D.J. Profilin 1 is essential for cell survival and cell division in early mouse development. Proc. Natl. Acad. Sci. USA 98 (2001) 3832-3836
54. Xu W., Edmondson D.G., Evrard Y.A., Wakamiya M., Behringer R.R., and Roth S.Y. Loss of Gcn5l2 leads to increased apoptosis and mesodermal defects during mouse development. Nat. Genet. 26 (2000) 229-232
55. Yu Q., Shen Y., Chatterjee B., Siegfried B.H., Leatherbury L., Rosenthal J., Lucas J.F., Wessels A., Spurney C.F., Wu Y.J., Kirby M.L., Svenson K., and Lo C.W. ENU induced mutations causing congenital cardiovascular anomalies. Development 131 (2004) 6211-6223
56. Yuba-Kubo A., Kubo A., Hata M., and Tsukita S. Gene knockout analysis of two gamma-tubulin isoforms in mice. Dev. Biol. 282 (2005) 361-373
57. Zarbalis K., May S.R., Shen Y., Ekker M., Rubenstein J.L., and Peterson A.S. A focused and efficient genetic screening strategy in the mouse: identification of mutations that disrupt cortical development. PLoS Biol. 2 (2004) E219
58. Zheng B., Sage M., Cai W.W., Thompson D.M., Tavsanli B.C., Cheah Y.C., and Bradley A. Engineering a mouse balancer chromosome. Nat. Genet. 22 (1999) 375-378